Примери за използване на Lawsonia на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Henna is made from a plant called Lawsonia.
The Lawsonia irnemis has astringent properties and reinforcing.
Natural henna is a powder of the plant Lawsonia Inermis.
Henna(Lawsonia inermis I.) is a bush of subtropical regions.
The henna is powdered leaves of the plant Lawsonia inermis.
The tiamulin MIC data determined for the available EU Lawsonia strains are all below the estimated ileal tiamulin contents of 0.63 μg/ml.
Henna is a powder from the dried leaves of the plant called Lawsonia.
Due to technical constraints the susceptibility of Lawsonia intracellularis is difficult to test in vitro.
In vitro studies as well as clinical efficacy data show that the lincomycin-spectinomycin combination is active against Lawsonia intracellularis.
Resistance to tylvalosin by Mycoplasma hyopneumoniae and Lawsonia intracellularis has not been reported or found in the field to date.
Henna” actually means“red”,it is a Latin name of the plant Lawsonia inermis.
Henna powder is powdered leaves of Lavsonia,that is, Lawsonia inermis shrub that grows and is cultivated in India, Egypt, Sudan, Iran, as well as in Pakistan, Nepal, Egypt.
Treatment of Porcine Proliferative Enteropathy caused by Lawsonia intracellularis.
Due to technical constraints the susceptibility of Lawsonia intracellularis is difficult to test in vitro, and data about the resistance status in that species are lacking.
Iii For the treatment of Porcine Proliferative Enteropathy(ileitis)caused by Lawsonia intracellularis.
Treatment of Porcine Proliferative Enteropathy caused by Lawsonia intracellularis in herds where there is a diagnosis based on clinical history, post-mortem findings and clinical pathology results.
Treatment of clinical signs of porcine proliferative enteropathy(ileitis)caused by Lawsonia intracellularis.
For the treatment and metaphylaxis of porcine proliferative enteropathy(ileitis)caused by Lawsonia intracellularis, and associated enteric pathogens(Escherichia coli) susceptible to lincomycin and spectinomycin.
Tiamulin has shown in-vitro activity against a wide range of bacteria including Brachyspira hyodysenteriae,Brachyspira pilosicoli, Lawsonia intracellularis and Mycoplasma spp.
This suggests that reduced sensitivity of individual Lawsonia strains can occur but as there have been no reported adverse events in the EU regarding treatment of ileitis failures it suggests that such reduced sensitivity has not developed extensively in the EU.
These products are effective medicines for the treatment of several diseases such as respiratory disease andileitis/porcine intestinal adenopathy(caused by Lawsonia intracellularis).
In contrast, premix formulations authorised for the treatment andprevention of ileitis(caused by Lawsonia intracellularis) most often recommend treatment for not longer than up to three weeks.
Extensive data are available in relation to the treatment of swine dysentery caused by Brachyspira hyodysenteriae and associated enteric pathogens, andfor the treatment of porcine proliferative enteropathy caused by Lawsonia intracellularis.
For the treatment and prevention of dysentery caused by Brachyspira hyodysenteria and for the treatment and prevention of porcine proliferative enteropathy(ileitis)caused by Lawsonia intracellularis, and associated enteric pathogens(Escherichia coli).